SUBPHENOTYPES IN COVID-19 ARDS: SECONDARY ANALYSIS OF A RANDOMIZED CLINICAL TRIAL

ABSTRACT

This is the first study showing that the application of a subphenotype strategy employing only widely available clinical variables is feasible in a cohort of COVID-19 ARDS patients. B Introduction/Hypothesis: b Acute respiratory distress syndrome (ARDS) is a heterogeneous condition. B Conclusions: b When applying subphenotypes previously found in ARDS cohorts to COVID-19 patients with ARDS, the same differential clinical, laboratorial and outcome characteristics were observed. [Extracted from the article] Copyright of Critical Care Medicine is the property of Lippincott Williams & Wilkins and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)